Research and Markets (http://www.researchandmarkets.com/research/xqkjg6/pipeline_analysis) has announced the addition of the "Pipeline Analysis of Hospital Acquired Pneumonia Drugs - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering.
Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused due to multidrug resistant microorganisms. The report analyzes the market for late stage candidates for treatment of nosocomial pneumonia, and also provides a detailed review of drugs in early stages of clinical trials. The report studies and estimates market for six late stage along with an elucidation of ten early stage candidates for nosocomial pneumonia treatment.
Global market for hospital acquired pneumonia drugs is mainly driven by the increasing prevalence of nosocomial infections across the globe. To illustrate this fact, the report includes a statistical comparison of the prevalence of nosocomial infections in various developed and developing countries. Geographical trend of hospital acquired pneumonia drugs market, is explains with a brief regulatory approval process, along with expected time frame for drug launch in various countries. These trends have been explained for geographical regions including North America, Europe, Asia Pacific and Rest of the World.
Key companies in the market include:
- Achaogen, Inc.
- Aridis Pharmaceutical
- AstraZeneca PLC
- Basilea Pharmaceutica Ltd.
- Bayer Healthcare
- Cubist Pharmaceutical
- GlaxoSmithKline
- Meiji Seika Pharma Co., Ltd.
- Merck & Co.
- Valneva SE.
Scope of the Report
Pipeline Analysis
- Tedizolid Phosphate
- Ceftolozane/Tazobactam
- Ceftazidime/Avibactam
- Amikacin Inhale
- Plazomicin
- Synflorix
For more information visit http://www.researchandmarkets.com/research/xqkjg6/pipeline_analysis
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
